InnovAge Holding Corp.
INNV
Positions held
Your positionsINNV isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- InnovAge Holding Corp. operates in the growing healthcare sector, focusing on medical care facilities, which are essential as the population ages.
- In the latest quarter, InnovAge reported a revenue increase of 4% compared to the prior quarter, reaching $262 million.
- The company's operating margin expanded to 5%, indicating improved operational efficiency.
- The company has a strong sell signal with a score of -16.00, reflecting significant bearish trends in its stock performance.
- InnovAge's net income for the year 2026 is projected to be -2.537 million, continuing a trend of negative profitability.
- The gross margin decreased slightly to 23.9% from 24.2% in the prior quarter, indicating potential challenges in maintaining profitability.
Fundamentals
| Market cap | $1.24B | Enterprise value | $1.22B | Trailing P/E | — | Forward P/E | 18.22 |
| PEG | — | Price / book | 5.26 | Beta | 0.15 | Dividend yield | 0.00% |
| Revenue growth | 18.3% | Earnings growth | — | Gross margin | 68.5% | Operating margin | 5.0% |
| Profit margin | -0.3% | ROE | -0.3% | ROA | 0.7% | Debt / equity | 0.32 |
| Current ratio | 1.05 | Free cash flow | $49.48M | Analyst recommendation | none | Mean target | $12.00 |
| 52w high | $12.64 | 52w low | $3.94 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $262M | $252M | $240M | $236M | $221M | — |
| Op margin | 5.0% | -11.5% | 5.5% | 3.6% | 1.3% | — |
| Net income | $8.3M | -$29.5M | $10.6M | $8.0M | -$0.8M | — |
| Gross margin | 23.9% | 24.2% | 22.0% | 21.8% | 18.6% | — |
| Gross profit | $62.6M | $61.0M | $52.8M | $51.4M | $41.3M | — |
| Operating income | $13.2M | -$29.1M | $13.3M | $8.4M | $3.0M | — |
- Revenue +4% vs prior quarter ($262M vs $252M).
- Gross margin 23.9% (was 24.2% prior quarter).
- Operating margin expanded to 5%.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $990M | $854M | $764M | $688M | — |
| Op margin | 0.6% | -1.9% | -3.0% | -7.2% | — |
| Net income | -$2.5M | -$30.3M | -$21.3M | -$40.7M | — |
| Gross margin | 23.0% | 18.0% | 17.3% | 14.7% | — |
| Gross profit | $228M | $154M | $132M | $101M | — |
| Operating income | $5.8M | -$16.1M | -$23.2M | -$49.4M | — |
Headlines — watch
• [WARN · balance sheet] InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders
• [WARN · balance sheet] InnovAge Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders
• [WARN · balance sheet] InnovAge Prices Secondary Offering of 10 Million Shares
• [WARN · balance sheet] InnovAge Reports Launch of Secondary Offering of Shares
News
2026-09-27 · InnovAge Holding (INNV), Why Is It Getting Fresh Attention?
2026-09-23 · InnovAge Prices Secondary Offering of 10 Million Shares
2026-09-23 · InnovAge Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders
2026-09-22 · InnovAge Reports Launch of Secondary Offering of Shares
2026-09-22 · InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders
2026-09-16 · Caris Life Sciences, Inc. (CAI) Soars 9.4%: Is Further Upside Left in the Stock?
2026-09-11 · InnovAge (INNV) Reaches a 9.6% Adjusted EBITDA Margin. Can the PACE Recovery Last?
2026-09-09 · InnovAge (INNV) Q4 2026 Earnings Call Transcript
2026-09-09 · Top Midday Gainers
2026-09-09 · Sector Update: Healthcare Stocks Mixed Premarket Wednesday
2026-09-09 · Sector Update: Healthcare
2026-09-09 · InnovAge Holding Corp. Q4 2026 Earnings Call Summary
Price (daily)
Full chart · RSI · MACD · patterns